La-Z-Boy
- Market cap
- 1.18B
- P/E (TTM)i
- 15.01
- P/Bi
- 1.17
- EPSi
- 2.47
- Div yieldi
- 3.20%
- 52W posi
- 8%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 102.48% +0.08pp
- Institutions
- 331 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 11 buys · 39 sells
| Name | Role | Stake |
|---|---|---|
| Melinda Whittington | Chief Executive Officer | 0.98% |
| Terrence Linz | President of Portfolio Brands | 0.16% |
| Robert Sundy | President of La-Z-Boy Brand & Chief Commercial Officer | 0.15% |
| Katherine Vanderjagt | VP & Chief Human Resources Officer | 0.14% |
| Raphael Richmond | VP, Chief Compliance Officer, Chief legal Officer & General Counsel | 0.13% |
| Michael Leggett | Senior VP & Chief Supply Chain Officer | 0.11% |
| Taylor Luebke | Senior Vice President | 0.09% |
| Carol Lee | VP & Chief Information Officer | 0.09% |
| Rebecca Reeder | President of Retail Furniture Galleries | 0.09% |
| Robert Lucian | Senior Vice President | 0.08% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-09 | Robert Sundy | President of La-Z-Boy Brand & Chief Commercial Officer | Open Market Disposition | -5,000 | $30.85 |
| 2026-09-07 | Janet Kerr | Independent Director | Automatic Disposition | -3,653 | $31.75 |
| 2026-08-26 | Lauren Peters | Independent Director | Other Acquisition | +4,125 | -- |
| 2026-08-26 | William Boor | Director | Other Acquisition | +4,125 | -- |
| 2026-08-26 | Janet Kerr | Independent Director | Other Acquisition | +4,125 | -- |
| 2026-08-26 | Michael Lawton | Independent Non-Executive Chairperson | Other Acquisition | +4,125 | -- |
| 2026-08-26 | Mark LaVigne | Independent Director | Other Acquisition | +4,125 | -- |
| 2026-08-26 | Rebecca O’Grady | Independent Director | Other Acquisition | +4,125 | -- |
| 2026-08-26 | Raza Haider | Independent Director | Other Acquisition | +4,125 | -- |
| 2026-08-26 | Matthew Baer | Director | Other Acquisition | +4,125 | -- |
| 2026-08-26 | Erika Alexander | Independent Director | Other Acquisition | +4,125 | -- |
| 2026-07-14 | Jennifer McCurry | Chief Accounting Officer | Sale to Issuer | -108 | $39.93 |
| 2026-07-14 | Carol Lee | VP & Chief Information Officer | Sale to Issuer | -122 | $39.93 |
| 2026-06-29 | Terrence Linz | President of Portfolio Brands | Open Market Disposition | -2,500 | $40.23 |
| 2026-06-28 | Raphael Richmond | VP, Chief Compliance Officer, Chief legal Officer & General Counsel | Derivative Exercise and Sale | -13,671 | $24.41–39.83 |
| 2026-06-27 | Melinda Whittington | Chief Executive Officer | Sale to Issuer | -9,757 | $40.95 |
| 2026-06-27 | Raphael Richmond | VP, Chief Compliance Officer, Chief legal Officer & General Counsel | Sale to Issuer | -925 | $40.95 |
| 2026-06-27 | Katherine Vanderjagt | VP & Chief Human Resources Officer | Sale to Issuer | -817 | $40.95 |
| 2026-06-27 | Terrence Linz | President of Portfolio Brands | Sale to Issuer | -956 | $40.95 |
| 2026-06-27 | Robert Sundy | President of La-Z-Boy Brand & Chief Commercial Officer | Sale to Issuer | -979 | $40.95 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:56:33 · For reference only, not investment advice and not tailored to your situation.